Vida Ventures Advisors’s Centessa Pharmaceuticals CNTA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-3,931,818
| Closed | -$65.9M | – | 4 |
|
|
2024
Q4 | $65.9M | Hold |
3,931,818
| – | – | 45.01% | 1 |
|
|
2024
Q3 | $62.9M | Hold |
3,931,818
| – | – | 45.36% | 1 |
|
|
2024
Q2 | $35.5M | Hold |
3,931,818
| – | – | 38.83% | 1 |
|
|
2024
Q1 | $44.4M | Hold |
3,931,818
| – | – | 24.68% | 2 |
|
|
2023
Q4 | $31.3M | Hold |
3,931,818
| – | – | 37.26% | 1 |
|
|
2023
Q3 | $25.4M | Hold |
3,931,818
| – | – | 39.38% | 1 |
|
|
2023
Q2 | $24.3M | Hold |
3,931,818
| – | – | 31.78% | 2 |
|
|
2023
Q1 | $15.1M | Hold |
3,931,818
| – | – | 20.71% | 2 |
|
|
2022
Q4 | $12.2M | Hold |
3,931,818
| – | – | 16.38% | 3 |
|
|
2022
Q3 | $15.8M | Hold |
3,931,818
| – | – | 14.18% | 4 |
|
|
2022
Q2 | $19.1M | Hold |
3,931,818
| – | – | 16.18% | 4 |
|
|
2022
Q1 | $35.3M | Hold |
3,931,818
| – | – | 20.51% | 1 |
|
|
2021
Q4 | $44.3M | Hold |
3,931,818
| – | – | 16.56% | 3 |
|
|
2021
Q3 | $65.7M | Hold |
3,931,818
| – | – | 18.81% | 1 |
|
|
2021
Q2 | $87.3M | Buy |
+3,931,818
| New | +$87.3M | 21.9% | 1 |
|